EX-4.84 7 ex4_84.htm EXHIBIT 4.84 ex4_84.htm
Exhibit 4.84
 
AMR101:  14 Day Dose Range Finding Toxicity Study in Dogs by Oral Gavage Administration 515147
 
Companies
 
APPENDIX 1
 
WORK ORDER
 
This WORK ORDER dated as of the date of last signature below
 
BETWEEN
 
(1)
AMARIN NEUROSCIENCE LTD of 1st Floor, Magdalen Centre North, The Oxford Science Park Oxford, OX44GA(“Amarin”)
 
(2)
AMARIN PHARMACEUTICALS IRELAND LIMITED having its principal place of business at First Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4, Ireland (“APIL”)
 
(3)
CHARLES RIVER LABORATORIES PRECLINICAL SERVICES EDINBURGH LIMITED having its principal place of business at Elphinstone Research Centre, Tranent, Edinburgh, EH33 2NE, UK (“Charles River”)
 
WHEREAS
 
A
Amarin, APIL and Charles River are bound by the terms of the Master Services Agreement dated 25 August 2008 between Amarin and Charles River (the “Master Services Agreement”)
 
B
The terms and conditions of the Master Services Agreement govern this Project Work Order in respect to the following project:  [AMR101:  14 Day Dose Range Finding Toxicity Study in Dogs by Oral Gavage Administration] (the “Project”), with the following additional provisions applying:

 
Schedule 1
Project Protocol
Schedule 2
Timelines
Schedule 3
Budget and Payment Schedule
Schedule 4
Budget Breakdown

This Work Order has an Effective Date as of the last date of signature and will remain valid until completion of Services described herein and when Amarin has paid the final invoice in accordance with the terms of the Master Services Agreement.

 
 

 

AGREED AND ACCEPTED by the parties
 

For and on behalf of Amarin Neuroscience Ltd
 
Signed ________________________________
Date ___________________________
   
Name   ________________________________
Position  ________________________

For and on behalf of Amarin Pharmaceuticals Ireland Limited
 
Signed ________________________________
Date ___________________________
   
Name   ________________________________
Position  ________________________

For and on behalf of Charles River Laboratories Preclinical Services Edinburgh Limited
 
Signed ________________________________
Date ___________________________
   
Name   ________________________________
Position  ________________________

 


 
-2-

 

SCHEDULE 1:  PROJECT PROTOCOL
 
AMR101:  14 Day Dose Range Finding
Toxicity Study In Dogs by Oral Gavage Administration
Charles River Study Number 515147

 
-3-

 

SCHEDULE 2.:  TIMELINES
 
Animal Arrival (Stock):
10 April 2008
   
First day of dosing (Day 1):
16 September 2008
   
Last day of dosing (Day 14):
29 September 2008
   
Terminal necropsies (Day 15):
30 September 2008
   
Completion of Experimental Work:
30 September 2008
   
Non-QA Draft Report:
21 November


 
-4-

 

SCHEDULE 3:  BUDGET AND PAYMENT SCHEDULE
 
·  
All invoices will be issued in Pound Sterling and are to be paid in Pound Sterling.
 
·  
The total cost far the Services detailed In this Work Order is £26,000 and the total estimated related expanses have been detailed in Schedule 4.
 
·  
The authorised Amarin contact shall be Trevor Wyeth.
 
·  
The authorised Charles River contact for this work shall be Catherine Nichols.
 
·  
All invoices will state the Amarin protocol number, activity performed, purchase order number (if available), contact name and will be submitted to the following address:
 

Amarin Neurosciences Ltd
 
1st Floor
Magdalen Centre North
The Oxford Science Park
Oxford
OX4 4GA
 
With a copy sent to:
 
Amarain Pharmaceuticals Ireland Limited
1st Floor, Block 3
The Oval
Shelbourne Road
Ballsbridge
Dublin 4
Ireland

Payment Schedule
 
Signature of Contract:
30% of Budget - £7,800
Start of Experimental Work:
40% of Budget - £10,400
Completion of Experimental Work:
20% of Budget - £5,200
Unaudited Drafted Report:
10% of Budget - £2,600


 
-5-

 

SCHEDULE 4:  BUDGET BREAKDOWN
 
The budget breakdown is detailed below:
 
Purchase and Pretrial housing of Animals
3,000
   
Study Management & Reporting
12,300
   
Formulation, including test item receipt
1,000
   
Housing, Dosing and animal room data collection
4,000
   
Necropsy
1,700
   
Clinical Pathology
4,000
   
Grand Total
26,000

 
Expenses – Estimates
 
(to be inserted)

 
 
 
-6-